"Biotech companies face distinct challenges in implementing social media programs because they focus on highly specialized markets, face regulatory restrictions on promoting their products, and cope with limitations on their interactions with physicians and patients. In this session, attendees will learn how some drug companies have overcome regulatory and legal concerns and are using blogs, online communities and other social media approaches to strengthen corporate reputation, manage issues and support product launches."

Objective1:Present lessons learned to public relations and marketing professionals to better position themselves to implement social media practices.

Objective2:Reveal how social media can improve a company's ability to communicate with its stakeholders.

Objective3:Show that social media does not have to be complicated or expensive.